Cargando…

Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model

BACKGROUND: Synucleinopathies comprise a group of neurodegenerative diseases associated with abnormal accumulation of α-synuclein. One of the key factors that contribute to the progression of synucleinopathies is neuroinflammation. However, the role of lymphocytes in synucleinopathies like Parkinson...

Descripción completa

Detalles Bibliográficos
Autores principales: Sommer, Annika, Fadler, Tanja, Dorfmeister, Eva, Hoffmann, Anna-Carin, Xiang, Wei, Winner, Beate, Prots, Iryna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929755/
https://www.ncbi.nlm.nih.gov/pubmed/27364890
http://dx.doi.org/10.1186/s12974-016-0632-5
_version_ 1782440650709401600
author Sommer, Annika
Fadler, Tanja
Dorfmeister, Eva
Hoffmann, Anna-Carin
Xiang, Wei
Winner, Beate
Prots, Iryna
author_facet Sommer, Annika
Fadler, Tanja
Dorfmeister, Eva
Hoffmann, Anna-Carin
Xiang, Wei
Winner, Beate
Prots, Iryna
author_sort Sommer, Annika
collection PubMed
description BACKGROUND: Synucleinopathies comprise a group of neurodegenerative diseases associated with abnormal accumulation of α-synuclein. One of the key factors that contribute to the progression of synucleinopathies is neuroinflammation. However, the role of lymphocytes in synucleinopathies like Parkinson’s disease (PD) remains largely unclear. METHODS: To investigate how lymphocytes impact synucleinopathies, human wild-type α-synuclein (WTS) transgenic mice were crossed with mice lacking mature lymphocytes (Rag2(−/−)). In this in vivo model, we quantified α-synuclein aggregation in the substantia nigra (SN) and striatum and determined the numbers of innate and adaptive immune cells in the central nervous system (CNS). The activation state of resident and infiltrated CNS myeloid cells (M1 vs. M2) was further classified by gene and protein expression analyses. The impact of T and B lymphocytes on the phagocytic activity of microglia in the presence of α-synuclein aggregates was addressed in BV2 microglia in vitro. RESULTS: Compared to WTS(+) Rag2(+/+) mice, where T but not B lymphocytes infiltrated the CNS, decreased amounts of α-synuclein aggregates were found in WTS(+) Rag2(−/−) mice devoid of mature lymphocytes. The presence of T lymphocytes did not alter the number of Iba1(+) microglia but increased the frequency of the CD11b(+) CD45(hi) population in the CNS, indicative of an increased number of infiltrated macrophages. Moreover, the M1 phenotype was more prominent in WTS(+) Rag2(+/+) mice, whereas the M2 activation state was dominating in the absence of lymphocytes in WTS(+) Rag2(−/−) mice. In vitro, in the presence of T but not B lymphocytes, significantly less α-synuclein was phagocytosed by BV2 microglia, further supporting the prevalence of the M1 phenotype in the presence of T lymphocytes. CONCLUSIONS: Peripheral T lymphocytes strongly contribute to increased α-synuclein pathology via modulation of CNS myeloid cell function. In the presence of T lymphocytes, microglia phagocytosis of aggregated α-synuclein is reduced, which increases the severity of synucleinopathy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-016-0632-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4929755
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49297552016-07-02 Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model Sommer, Annika Fadler, Tanja Dorfmeister, Eva Hoffmann, Anna-Carin Xiang, Wei Winner, Beate Prots, Iryna J Neuroinflammation Research BACKGROUND: Synucleinopathies comprise a group of neurodegenerative diseases associated with abnormal accumulation of α-synuclein. One of the key factors that contribute to the progression of synucleinopathies is neuroinflammation. However, the role of lymphocytes in synucleinopathies like Parkinson’s disease (PD) remains largely unclear. METHODS: To investigate how lymphocytes impact synucleinopathies, human wild-type α-synuclein (WTS) transgenic mice were crossed with mice lacking mature lymphocytes (Rag2(−/−)). In this in vivo model, we quantified α-synuclein aggregation in the substantia nigra (SN) and striatum and determined the numbers of innate and adaptive immune cells in the central nervous system (CNS). The activation state of resident and infiltrated CNS myeloid cells (M1 vs. M2) was further classified by gene and protein expression analyses. The impact of T and B lymphocytes on the phagocytic activity of microglia in the presence of α-synuclein aggregates was addressed in BV2 microglia in vitro. RESULTS: Compared to WTS(+) Rag2(+/+) mice, where T but not B lymphocytes infiltrated the CNS, decreased amounts of α-synuclein aggregates were found in WTS(+) Rag2(−/−) mice devoid of mature lymphocytes. The presence of T lymphocytes did not alter the number of Iba1(+) microglia but increased the frequency of the CD11b(+) CD45(hi) population in the CNS, indicative of an increased number of infiltrated macrophages. Moreover, the M1 phenotype was more prominent in WTS(+) Rag2(+/+) mice, whereas the M2 activation state was dominating in the absence of lymphocytes in WTS(+) Rag2(−/−) mice. In vitro, in the presence of T but not B lymphocytes, significantly less α-synuclein was phagocytosed by BV2 microglia, further supporting the prevalence of the M1 phenotype in the presence of T lymphocytes. CONCLUSIONS: Peripheral T lymphocytes strongly contribute to increased α-synuclein pathology via modulation of CNS myeloid cell function. In the presence of T lymphocytes, microglia phagocytosis of aggregated α-synuclein is reduced, which increases the severity of synucleinopathy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-016-0632-5) contains supplementary material, which is available to authorized users. BioMed Central 2016-06-30 /pmc/articles/PMC4929755/ /pubmed/27364890 http://dx.doi.org/10.1186/s12974-016-0632-5 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Sommer, Annika
Fadler, Tanja
Dorfmeister, Eva
Hoffmann, Anna-Carin
Xiang, Wei
Winner, Beate
Prots, Iryna
Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model
title Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model
title_full Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model
title_fullStr Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model
title_full_unstemmed Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model
title_short Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model
title_sort infiltrating t lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929755/
https://www.ncbi.nlm.nih.gov/pubmed/27364890
http://dx.doi.org/10.1186/s12974-016-0632-5
work_keys_str_mv AT sommerannika infiltratingtlymphocytesreducemyeloidphagocytosisactivityinsynucleinopathymodel
AT fadlertanja infiltratingtlymphocytesreducemyeloidphagocytosisactivityinsynucleinopathymodel
AT dorfmeistereva infiltratingtlymphocytesreducemyeloidphagocytosisactivityinsynucleinopathymodel
AT hoffmannannacarin infiltratingtlymphocytesreducemyeloidphagocytosisactivityinsynucleinopathymodel
AT xiangwei infiltratingtlymphocytesreducemyeloidphagocytosisactivityinsynucleinopathymodel
AT winnerbeate infiltratingtlymphocytesreducemyeloidphagocytosisactivityinsynucleinopathymodel
AT protsiryna infiltratingtlymphocytesreducemyeloidphagocytosisactivityinsynucleinopathymodel